Aim: The aim of the study was to explore fi ve years survival in women with endometrial cancer.
Material and methods: A retrospective review of 146 patients with endometrial cancer treated at Baskent University Hospital Gyne-oncologic Clinic in Ankara, Turkey between 2010 and 2015 was performed. Demographic and clinic-pathological data were compared with survival.
Results: The median age of the patients was 61.4 y±5.3 years (36-82). The overall 5-years survival was 89%. Multivariate Cox regression model revealed that the FIGO stage, grade, age, histological type, myometrial invasion, and lymph node involvement were all predictive factors on survival (p<0.05). owever, the menopausal status, age at menopause, parity, BMI, comorbidities, ECOG performance score, therapy modality, HR status, and family history were not associated with survival (p>0.05).
Conclusion: The results of our study, several clinic-pathological prognostic factors of EC have been identifi ed on survival. These results provided signifi cant evidence that early foresight of EC survival. Further prospective randomized studies are necessary to clarify the role of these factors.
Published on: Feb 22, 2017 Pages: 12-15
Former member of MGH, USA
International Journal of Immunotherapy and Cancer Research
Cardiometabolic Research Institute, USA
Journal of Cardiovascular Medicine and Cardiology
Journal of Addiction Medicine and Therapeutic Science
University of Nantes, France
Archives of Depression and Anxiety
ReGenera R&D International for Aging Intervention & San Babila Clinic, Milano, Italy
Archives of Clinical Gastroenterology